What is LOPJLB’s current signal on STRO?

LOPJLB’s latest quantitative signal on Sutro Biopharma, Inc. (STRO) is SELL in a CRISIS regime. Signals are updated daily.

What market regime is STRO in?

Sutro Biopharma, Inc. (STRO) is currently classified in the CRISIS HMM market regime on LOPJLB.

What does Sutro Biopharma, Inc. (STRO) do?

Sutro Biopharma, Inc. is a clinical-stage biotechnology company focused on the discovery, development, and manufacturing of innovative therapeutic products. Its primary objective is to create protein-based treatments for challenging conditions like cancer and autoimmune disorders. The company achieves this through its proprietary XpressCF+ platform, a unique technology that integrates cell-free…

Where is Sutro Biopharma, Inc. based / listed?

Sutro Biopharma, Inc. is based in US, listed on NASDAQ.

Sutro Biopharma, Inc. (STRO)

COMPARE

Healthcare · Biotechnology · NASDAQ · US

$14.27-6.85%Close

SELLCRISIS · day 42

RANGE

LOPJLB.COM

OHLCEMALEVELSSTOPFLIP52WSIGNALSBUYSELLEXHEXH ZONE

Key stats

Short interest · FINRA settlement 2026-09-30

Market cap: $138M
Beta: 1.49
P/E (TTM): -0.83

Short % float: 27.05%
Days to cover: 6.5
SI change: -11.0%

1W: -7.04%
1M: -19.97%

vs SPY 1W: -8.20%
vs SPY 1M: -22.96%

Industry peers

FMP comparable companies · ranked by market cap

STTKSELLShattuck Labs, Inc.$511MCRISISQ 5$5.66+5.48%

Prediction markets

Kalshi · Polymarket · … linked

Full prediction markets →

Loading markets…

Key stats

Industry peers

Prediction markets

Company news